Last update :
27/11/2024
Anticancer drug   Cytarabine  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Alexan Austria, Chile, Colombia, Egypt, Germany, Hungary, Luxembourg, Netherlands, Republic of South Africa, russian, Saudi Arabia, Thailand, Turkey, United Arab Emirates
Alexane Iran
Ara Cell Germany, Portugal
Arabine Denmark, Finland, Iceland, Sweden
Aracytin Brazil, Chile, Colombia, Egypt, Greece, Italy
Aracytine Colombia, France, Morocco
Cancyt India
Citab Brazil
Citarabina Argentina, Chile, Colombia, Ecuador, Italy, Mexico, Spain
Cylocide Japan
Cytaban Colombia
Cytaloxan Portugal
Cytarabine Australia, Belgium, Canada, Denmark, Egypt, Finland, Great Britain, Ireland, Malaysia, New Zealand, United Arab Emirates, United States of America
Cytarax Brazil, Mexico
Cytonal Turkey
Cytosafe Great Britain
Cytosar Austria, Belgium, Canada, Croatia, Denmark, Hungary, Iran, Ireland, Luxembourg, Malaysia, Netherlands, Norway, Poland, Portugal, Republic of South Africa, Saudi Arabia, Switzerland, United Arab Emirates, Venezuela
Ifarab Mexico
Laracit Chile, Colombia, Mexico
Medsara Mexico
Novutrax Colombia, Mexico
Oncorab Venezuela
Tabine Ecuador
Udicil Germany
Zuphacit Mexico
Stability in solutions   injection   Stability in solutions : Cytarabine     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 0,1 & 20 mg/ml 2-8°C Protect from light
28 Day
2255
Manufacturer's stability data

Glass NaCl 0,9% or Glucose 5% 0,144 mg/ml 23°C Protect from light
72 Hour
1501
Level of evidence A

Glass NaCl 0,9% or Glucose 5% 0,144 mg/ml 4°C Protect from light
72 Hour
1501
Level of evidence A

Glass NaCl 0,9% or Glucose 5% 20 mg/ml 20-25°C With or without light
28 Day
2255
Manufacturer's stability data

Glass Sodium chloride 0,9% 0,1 mg/ml 20-25°C With or without light
28 Day
2255
Manufacturer's stability data

Glass Sodium chloride 0,9% 1 mg/ml 2-8°C Protect from light
28 Day
4455
Level of evidence A

Glass Sodium chloride 0,9% 1 mg/ml 25°C Protect from light
14 Day
4455
Level of evidence A

Glass Sodium chloride 0,9% 10 mg/ml 2-8°C Protect from light
28 Day
4455
Level of evidence A

Glass Sodium chloride 0,9% 10 mg/ml 25°C Protect from light
5 Day
4455
Level of evidence A

Glass Sodium chloride 0,9% 5 mg/ml 2-8°C Protect from light
28 Day
4455
Level of evidence A

Glass Sodium chloride 0,9% 5 mg/ml 25°C Light
7 Day
739
Joker

Glass Sodium chloride 0,9% 5 mg/ml 25°C Protect from light
8 Day
4455
Level of evidence A

Glass Glucose 5% 0,1 mg/ml 20-25°C With or without light
14 Day
2255
Manufacturer's stability data

Glass Ringer’s lactate solution 5 mg/ml 25°C Light
7 Day
739
Joker

Glass Elliott’s B solution 3 mg/ml 23°C Not specified
48 Hour
31
Joker

Glass Elliott’s B solution 3 mg/ml 4°C Protect from light
48 Hour
31
Joker

Glass Elliott’s B solution 5 mg/ml 25°C Light
7 Day
739
Joker

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,1 & 20 mg/ml 2-8°C Protect from light
28 Day
2255
Manufacturer's stability data

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,144 mg/ml 23°C Protect from light
72 Hour
1501
Level of evidence A

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,144 mg/ml 4°C Protect from light
72 Hour
1501
Level of evidence A

Polyvinyl chloride NaCl 0,9% or Glucose 5% 20 mg/ml 20-25°C With or without light
28 Day
2255
Manufacturer's stability data

Polyvinyl chloride Sodium chloride 0,9% 0,1 mg/ml 20-25°C With or without light
28 Day
2255
Manufacturer's stability data

Polyvinyl chloride Glucose 5% 0,1 mg/ml 20-25°C With or without light
14 Day
2255
Manufacturer's stability data

Polyethylene NaCl 0,9% or Glucose 5% 0,1 & 20 mg/ml 2-8°C Protect from light
28 Day
2255
Manufacturer's stability data

Polyethylene NaCl 0,9% or Glucose 5% 0,144 mg/ml 21°C-22°C Not specified
72 Hour
1520
Manufacturer's stability data

Polyethylene NaCl 0,9% or Glucose 5% 0,144 mg/ml 23°C Protect from light
72 Hour
1501
Level of evidence A

Polyethylene NaCl 0,9% or Glucose 5% 0,144 mg/ml 4°C Protect from light
72 Hour
1501
Level of evidence A

Polyethylene NaCl 0,9% or Glucose 5% 0,144 mg/ml 4°C Not specified
72 Hour
1520
Manufacturer's stability data

Polyethylene NaCl 0,9% or Glucose 5% 20 mg/ml 20-25°C With or without light
28 Day
2255
Manufacturer's stability data

Polyethylene Sodium chloride 0,9% 0,1 mg/ml 20-25°C With or without light
28 Day
2255
Manufacturer's stability data

Polyethylene Glucose 5% 0,1 mg/ml 20-25°C With or without light
14 Day
2255
Manufacturer's stability data

Polypropylene Glucose 5% 0,157 mg/ml 25°C With or without light
48 Hour
152
Joker

Polypropylene Glucose 5% 0,157 mg/ml 4°C With or without light
48 Hour
152
Joker

Ethylene vinyl acetate NaCl 0,9% or Glucose 5% 1,25 & 25 mg/ml 22°C Protect from light
28 Day
142
Joker

Ethylene vinyl acetate NaCl 0,9% or Glucose 5% 1,25 & 25 mg/ml 25°C Protect from light
28 Day
844
Joker

Ethylene vinyl acetate NaCl 0,9% or Glucose 5% 1,25 & 25 mg/ml 35°C Protect from light
7 Day
142
Joker

Ethylene vinyl acetate NaCl 0,9% or Glucose 5% 1,25 & 25 mg/ml 35°C Protect from light
14 Day
844
Joker

Ethylene vinyl acetate NaCl 0,9% or Glucose 5% 1,25 & 25 mg/ml 4°C Protect from light
28 Day
142
Joker

Ethylene vinyl acetate NaCl 0,9% or Glucose 5% 1,25 & 25 mg/ml 4°C Protect from light
28 Day
844
Joker

Polypropylen Syringe Water for Injection 20 & 50 mg/ml 21°C Protect from light
30 Day
1229
Level of evidence C

Polypropylen Syringe Water for Injection 20 & 50 mg/ml 6°C-9°C Protect from light
30 Day
1229
Level of evidence C

Polypropylen Syringe NaCl 0,9% or Glucose 5% 0,1 & 20 mg/ml 2-8°C Protect from light
28 Day
2255
Manufacturer's stability data

Polypropylen Syringe NaCl 0,9% or Glucose 5% 20 mg/ml 20-25°C With or without light
28 Day
2255
Manufacturer's stability data

Polypropylen Syringe Sodium chloride 0,9% 0,1 mg/ml 20-25°C With or without light
28 Day
2255
Manufacturer's stability data

Polypropylen Syringe Sodium chloride 0,9% 1 mg/ml 2-8°C Protect from light
28 Day
4455
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 1 mg/ml 25°C Protect from light
14 Day
4455
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 10 mg/ml 2-8°C Protect from light
28 Day
4455
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 10 mg/ml 25°C Protect from light
5 Day
4455
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 5 mg/ml 2-8°C Protect from light
28 Day
4455
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 5 mg/ml 25°C Protect from light
8 Day
4455
Level of evidence A

Polypropylen Syringe Glucose 5% 0,1 mg/ml 20-25°C With or without light
14 Day
2255
Manufacturer's stability data

Polypropylen Syringe Elliott’s B solution 3 mg/ml 23°C Not specified
48 Hour
31
Joker

Polypropylen Syringe Elliott’s B solution 3 mg/ml 4°C Protect from light
48 Hour
31
Joker

Polypropylen Syringe None 20 & 50 mg/ml -10°C Protect from light
14 Day
850
Level of evidence B

Polypropylen Syringe None 20 & 50 mg/ml 22°C Not specified
14 Day
850
Level of evidence B

Polypropylen Syringe None 20 & 50 mg/ml 8°C Protect from light
14 Day
850
Level of evidence B


  Mentions Légales